Trend of retinal diseases in developing countries

Expert Review of Ophthalmology

Volumn 3, Issue 1, 2008, Pages 43-50

  Hussain, Nazimul ^a   Khanna, Rohit ^a   Hussain, Anjli ^b  

^a L V PRASAD EYE INSTITUTE   (India)

^b Swarup Eye Centre   (India)

Author keywords

Age related macular degeneration; Diabetic retinopathy; Health education; Health promotion; Retinal blindness; Retinopathy of prematurity

Indexed keywords

ARTICLE; DEVELOPING COUNTRY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; HEALTH CARE DELIVERY; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; INCIDENCE; LIFE EXPECTANCY; NEWBORN INTENSIVE CARE; ONSET AGE; PREVALENCE; QUALITY OF LIFE; RACE DIFFERENCE; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINOPATHY; RETROLENTAL FIBROPLASIA; SOCIOECONOMICS; TERTIARY HEALTH CARE; VISUAL IMPAIRMENT;

EID: 47249153632     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/17469899.3.1.43     Document Type: Article

References (66)

1. Resnikoff S, Pascolini D, Etya'ale D et al. Global data on visual impairment in the year 2002. Bull. World Health Organ. 82 (11), 844-851 (2004).
2. Murthy GVS, Gupta SK, Bachani D, Jose R, John N. Current estimates o blindness in India. Br. J. Ophthalmol. 89, 257-260 (2005).
3. Angra SK, Murthy GV, Gupta SK et al. Cataract related blindness in India and its social implications. Indian J. Med. Res. 106, 312-324 (1997).
4. Hugo G. Over to the next century: continuities and discontinuities. In: Added Years of Life in Asia: Current Situations and Future Challenges. United Nations Publications, NY, USA (1996)
5. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ. 73(1), 115-121 (1995).
6. World Health Organization. Global initiative for the elimination of avoidable blindness. Programme for prevention of blindness and deafness. WHO, Geneva, Switzerland WHO/PBL/97.61 (1997).
7. A Smith AF, Smith JG. The economic burden of global blindness: a price too high! Br. J. Ophthalmol. 80(4), 276-277 (1996).
8. Boutayeb A. The double burden of communicable and non-communicable diseases in developing countries. Trans. R. Soc. Trop. Med. Hyg. 100(3), 191-199 (2006).
9. Wild S, Roglic G, Green A et al. Global prevalence of diabetes, estimated for year 2000 and projection for 2030. Diabetes Care 27, 1047-1053 (2004)
10. Ramachandran A. Epidemiology of diabetes research in India - Three decades of research. J. Assoc. Physicians India 53, 34-38 (2005).
11. Ramachandran A, Snehalatha C, Baskar AD et al. Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia. 47(5), 860-865 (2004).
12. Mohan V, Deepa M, Deepa R et al. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban south India - the Chennai Urban Rural Epidemiology Study (CURES - 17). Diabetologia 49, 1175-1178 (2006).
13. Katulanda P, Sheriff MH, Matthews DR. The diabetes epidemic in Sri Lanka - a growing problem. Ceylon Med. J. 51 (1), 26-28 (2006).
14. Illangasekera U, Rambodagalla S, Tennakoon S. Temporal trends in the prevalence of diabetes mellitus in a rural community in Sri Lanka. J. R. Soc. Health 124(2), 92-94 (2004).
15. Halimi S. Diabetes in 2005. Nephrol. Ther. 2(Suppl. 1) S2-S7 (2006).
16. Ramachandran A, Ramachandran S, Snehalatha C et al. Increasing expenditure on health care incurred by diabetic subjects in a developing country: a study from India. Diabetes Care 30(2), 252-256 (2007).
17. Eljedi A, Mikolajczyk RT, Kraemer A, Laaser U. Health-related quality of life in diabetic patients and controls without diabetes in refugee camps in the Gaza strip: a cross-sectional study. BMC Public Health. 6, 268 (2006).
18. Rema M, Ponnaiya M, Mohan V. Prevalence of retinopathy in non insulin dependent diabetes mellitus at a diabetes centre in Southern India. Diabetes Res. Clin. Pract. 34, 29-36 (1996).
19. Rema M, Deepa R, Mohan V. Prevalence of retinopathy at diagnosis among type 2 diabetic patients attending a diabetic centre in South India. Br. J. Ophthalmol. 84, 1058-1060 (2000).
20. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in southern India. Br. J. Ophthalmol. 83, 937-940 (1999).
21. Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self reported diabetics in southern India: a population based assessment. Br. J. Ophthalmol. 86, 1014-1018 (2002).
22. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I. Invest. Ophthalmol. Vis. Sci. 4, 2328-2333 (2005).
23. Klein R, Davis MD, Moss SE, Klein BE, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy a comparision of retinopathy in younger and older onset diabetic person. Adv. Exp. Med. Biol. 189, 321-335 (1985).
24. Klein R, Klein BE, Linton KL. Ophthalmology. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99(6), 933-943 (1992).
25. Mitchell P, Smith W. Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102(10), 1450-1460 (1995).
26. Vingerling JR, Dielemans I, Hofman A et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102(2), 205-210 (1995).
27. Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsch JM. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology 106(6), 1049-1055 (1999).
28. Oshima Y, Ishibashi T, Murata T et al. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br. J. Ophthalmol. 85, 1153-1157 (2001).
29. Nirmalan PK, Katz J, Robin AL et al. Prevalence of vitreoretinal disorders in a rural population of southern India. The Aravind Comprehensive Eye Study. Arch. Ophthalmol. 122, 581-586 (2004).
30. Li Y, Xu L, Jonas JB, Yang H, Ma Y, Li J. Prevalence of age related maculopathy in adult population in china: the Beijing Eye Study. Am. J. Ophthalmol. 142, 788-793 (2006).
31. Krishnaiah S, Das T, Nirmalan PK et al. Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in SouthIndia. Invest. Ophthalmol. Vis. Sci. 46(12), 4442-4449 (2005).
32. Gupta SK, Murthy GV, Morrison N et al. Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study. Invest. Opthalmol. Vis. Sci. 48(3), 1007-1011 (2007).
33. Dineen BP, Bourne RRA, Ali SM, Huq DMN, Johnson GJ. Prevalence of blindness and visual impairment in Bangladeshi adults: results of the National Blindness and Low Vision Survey of Bangladesh. Br. J. Ophthalmol. 87, 820-828 (2003).
34. Dineen BP, Bourne RRA, Jadoon Z et al. Causes of blindness and visual impairment in Pakistan. The Pakistan national blindness and visual impairment survey. Br. J. Ophthalmol. 91, 1005-1010 (2007).
35. Zou HD, Zhang X, Xu X et al. Prevalence study of age related macular degeneration in Caojiadu blocks, Shanghai. J. Zhonghua Yan Ke Za Zhi. 41, 15-19 (2005).
36. Xu L, Wang Y, Li Y et al. Causes of Blindness and Visual impairment in Urban and Rural areas in Beijing. The Beijing Eye Study. Ophthalmology 113, 1134-1141 (2006).
37. Dandona R, Dandona L. Childhood blindness in India. A population based perspective. Br. J. Ophthalmol. 87, 263-265 (2003)
38. World Health Organization. Global initiative for the elimination of avoidable blindness. Programmes for the prevention of blindness and deafness, and international agency for prevention of blindness. WHO, Geneva, Switzerland. WHO/PBL/00.77) (2000).
39. Gogate P, Deshpande M, Sudrik S, Taras S, Kishore H, Gilbert C. Changing pattern of childhood blindness in maharasthra, India. Br. J. Ophthalmol. 91, 8-12 (2007).
40. Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats DK. Childhood blindness. J. AAPOS3, 26-32 (1999).
41. Sharma R, Gupta VP, Dhaliwal U, Gupta P. Screening for retinopathy of prematurity in developing countries. J. Top. Pediatr 53(1), 52-54 (2007)
42. Aggarwal R, Deorari AK, Azad RV, Kumar H, Talwar D, Sethi A et al. Changing profile of retinopadiy of prematurity. J. Trop. Pediatr. 48(4), 239-242 (2002).
43. Rekha S, Battu RR. Retinopathy of prematurity: incidence and risk factors. Indian Pediatr. 33(12), 999-1003 (1996).
44. Charan R, Dogra MR, Gupta A, Narang A. The incidence of retinopathy of prematurity in a neonatal care unit. Indian J. Ophthalmol. 43(3), 123-126 (1995).
45. Delport SD, Swanepoel JC, Odendaal PJ, Roux P. Incidence of retinopathy of prematurity in very-low-birth-weight infants bom at kalafong Hospital, Pretoria. S. Afr. Med. J. 92(12), 986-990 (2002).
46. Duman N, Kumral A, Galcan H, Ozkan H. Outcome of very-low-birth-weight infants in developing country: a prospective study from western region of Turkey. J. Matern. Fetal Neonatal Med. 13(1), 54-58 (2003).
47. Phan MH, Nguyen PN, Reynolds JD. Incidence and severity of retinopathy of prematurity in Vietnam, a developing middle income country. J. Pediatr. Ophthalmol. Strabismus 40(4), 208-212 (2003).
48. Chen Y, Li X. Characteristics of severe retinopathy of prematurity patients in China: a repeat of the first epidemic? Br. J. Ophthalmol. 90(3), 268-271 (2006).
49. Fortes Filho JB, Barros CK, Da Costa MC, Procianoy RS. Results of a program for the prevention of blindness caused by retinopathy of prematurity in southern Brazil. J. Pediatr. 83(3), 209-216 (2007).
50. Jalali S, Matalia J, Hussain A, Anand R. Modification of screening criteria fbr retinopathy of prematurity in India and other middle income countries. Am. J. Ophthalmol. 141(5), 966-968 (2006).
51. Gilbert C, FielderA, Gordillo L, Quinn G, Semiglia R, Visintin P, Zin A and International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with Low, Moderate and High levels of development: Implications for screening programs. Pediatrics 115, e518-e525 (2005).
52. Cryotherapy for retinopathy of prematurity Co-operative Group. Multicenter trial of Cryotherapy for retinopathy of prematurity, Ophthalmological outcomes at 10 years. Arch Ophthalmol. 118, 119-111 (2001).
53. Global initiative for elimination of avoidable blindness: an informal consultation. WHO, Geneva, Switzerland (1997).
54. Thomas R, Paul P, Rao GN, Muliyil JP, Mathai A. Present status of eye care in India. Surv. Ophthalmol. 50, 85-101 (2005).
55. Gilbert C, Foster A. Childhood blindness in the context of VISION 2020 - The right to sight. Bull. World Health Organization 79, 227-232 (2001).
56. Kawasaki S, Ito S, Satoh S et al. Use of telemedicine in periodic screening of diabetic retinopathy. Telemed. J. E. Health 3, 235-239 (2003).
57. Hassell JB, Lamoureux EL, Keefe JE. Impact of age related macular degeneration on quality of life. Br. J. Ophthalmol. 90, 593-596 (2006).
58. Reeves BC, Harper RA, Russell WB. Enhanced low vision rehabilitation for people with age related macular degeneration: a randomized controlled trial. Br. J. Ophthalmol. 88, 1443-1449 (2004).
59. West SK, Munoz B, Rubin GS et al. Function and visual impairment in a population based study in older adults. Invest. Ophthalmol. Vis. Sci. 38, 72-82 (1997).
60. Khan SA, Das T, Kumar SM, Nutheti R. Low vision rehabilitation in patients with age related macular degeneration at a tertiary eye care in southern India. Clin. Exp. Ophthalmol. 30, 404-410 (2002).
61. Schmier Jk, Halpern MT, Covert D, Delgado J, Sharma S. Impact of visual impairment on use of care giving by individuals with age related maular dgeneration. Retina 26, 1056-1062 (2006).
62. Rover BW, Casten RJ. Activity loss and depression in age related macular degeneration. Am. J. Geriatr. Psychiatry 10(3), 305-310 (2002).
63. Mithchell J, Bradley C. Quality of life in age related macular degeneration: a review of the literature. Health and Quality of Life Outcomes. 4, 4-97 (2006).
64. Hubley J, Gilbert C. Eye health promotion and the prevention of blindness in developing countries: critical issues. Br. J. Ophthalmol. 90, 279-284 (2006).
65. Thulsiraj RD, Muralikrishnan R. Vision 2020: The global initiative for right to sight. Community ophthalmology 1, 20-22 (2001).
66. Yorstan D. Retinal disease and VISION 2020. Community Eye Health 16(46), 19-20 (2003).